Becton Dickinson Discontinuing Glucose Monitor Development Program
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson's decision not to introduce a stand-alone blood glucose monitoring product by year-end gives the company extra resources to focus further on its "strategic bullseye" represented by sharps protection, biosciences and insulin delivery.